Switch to:
More From Other Websites
Healthcare-Focused Michael Castor Added These Stocks to His Portfolio Last Quarter Sep 27 2016
ChemoCentryx Reports Initial Results from Ongoing Phase Ib Clinical Trial of CCX872 in Patients with... Sep 01 2016
ChemoCentryx to Present at the Baird 2016 Global Healthcare Conference Aug 25 2016
CHEMOCENTRYX, INC. Financials Aug 17 2016
Edited Transcript of CCXI earnings conference call or presentation 8-Aug-16 9:00pm GMT Aug 09 2016
CHEMOCENTRYX, INC. Files SEC form 10-Q, Quarterly Report Aug 09 2016
ChemoCentryx reports 2Q loss Aug 08 2016
ChemoCentryx reports 2Q loss Aug 08 2016
ChemoCentryx to Hold Second Quarter 2016 Financial Results Conference Call on Monday, August 8, 2016 Aug 08 2016
CHEMOCENTRYX, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Aug 08 2016
ChemoCentryx Reports Second Quarter 2016 Financial Results and Provides Corporate Update Aug 08 2016
Q2 2016 ChemoCentryx Inc Earnings Release - After Market Close Aug 08 2016
ChemoCentryx to Hold Second Quarter 2016 Financial Results Conference Call on Monday, August 8, 2016 Aug 01 2016
ChemoCentryx to Present at the Cantor Fitzgerald 2nd Annual Healthcare Conference Jun 29 2016
ChemoCentryx, Inc. :CCXI-US: Earnings Analysis: Q1, 2016 By the Numbers : June 6, 2016 Jun 06 2016
IBB Rose 0.9% before the Long Weekend May 31 2016
CHEMOCENTRYX, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders May 27 2016
XBI and IHI Rose despite the Biotechnology Sector’s Sluggish Week May 16 2016
CHEMOCENTRYX, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale... May 12 2016
Can The Uptrend Continue for ChemoCentryx (CCXI)? May 11 2016


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK